Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Newsroom
At Memorial Sloan Kettering Cancer Center, our world-renowned cancer researchers, oncologists, clinicians, and scientists are constantly advancing our knowledge about cancer. Our discoveries are improving treatment and care for patients here and all over the world. On this page, you will find news & information about our latest groundbreaking cancer science, exceptional patient care and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two cancer hospital in the nation, and the number one hospital for urology care by U.S. News & World Report in its annual Best Hospitals list. MSK has held its position as a top-two cancer hospital in the U.S. and the best cancer center in the Northeast since these rankings were established 35 years ago.
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
Memorial Sloan Kettering Cancer Center today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.
Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce The Washington Post has named Vinod Balachandran, MD, surgeon-scientist and Director of The Olayan Center for Cancer Vaccines at MSK, to the inaugural edition of the Post Next 50, a list of up-and-coming changemakers shaping society in 2025.
Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.
Cancer Straight Talk brings together national experts and cancer patients to have straightforward, evidence-based conversations. Medical oncologist Diane Reidy-Lagunes hosts this series with the mission of educating and empowering patients to make the right decisions and live happier, healthier lives.
